Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for treating nerve damage rather than only suppressing inflammation.

The benefits of frexalimab in people with relapsing MS have been sustained for up to three years in a clinical trial, data ...

In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in meaningful improvements in fatigue, a ...

Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition. A study led by the University of ...

Secondary progressive multiple sclerosis (SPMS) can develop after relapsing-remitting multiple sclerosis (RRMS). It causes steady neurological decline, either with or without relapses. Switching from ...

Women are less likely than men to receive drugs for multiple sclerosis (MS) between the ages of 18 to 40, during women's childbearing years, even when those drugs have been shown to be safe for use ...

Does MS cause pain? Should people with MS exercise? Many common beliefs about MS aren’t true, but here we separate fact from fiction.

Multiple Sclerosis is an autoimmune disease that affects the central nervous system.

Multiple Sclerosis is a neurological disorder that affects about 3 million people around the world While anyone can get MS ...

DNA damage from inflammation outpaces the cells’ ability to self-repair. The finding, in human brain cells and mice, could point to new MS treatments.

Rick Blum is meticulous about planning, ordering, and taking the medication he is prescribed to slow the progression of multiple sclerosis, a chronic and incurable neurological disorder that has ...

People with multiple sclerosis appear to have higher rates of thyroid problems than the general population. The link isn’t clear, but shared pathways and MS medication side effects may play a role. MS ...